Literature DB >> 3145406

Ordering promoter binding of class III transcription factors TFIIIC1 and TFIIIC2.

N Dean1, A J Berk.   

Abstract

The separation of the mammalian class III transcription factor TFIIIC into two functional components, termed TFIIIC1 and TFIIIC2, enabled an analysis of their functions in transcription initiation. Template competition assays were used to define the order with which these factors interact in vitro to form stable preinitiation complexes on the adenovirus VAI and Drosophila melanogaster tRNA(Arg) genes. The interaction between these genes and TFIIIC2, the factor that binds with high affinity to the B block, was both necessary and sufficient for template commitment. When either the VAI or tRNA(Arg) gene was preincubated with TFIIIC2 alone, transcription of a second gene added subsequently was excluded, indicating that TFIIIC2 bound stably to the first template. Furthermore, the interaction between TFIIIC2 and these genes must occur prior to that of TFIIIC1 or TFIIIB. Once TFIIIC2 was bound, TFIIIC1 could bind to the tRNA(Arg) and VAI genes, although its interaction with the VAI gene was less stable than that with the tRNA(Arg) gene. TFIIIB activity bound stably to the complex of both genes with TFIIIC2. These results demonstrate that TFIIIC2 is the first transcription factor to bind to these genes and that TFIIIB and TFIIIC1 can then interact in either order to form a preinitiation complex.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3145406      PMCID: PMC363527          DOI: 10.1128/mcb.8.8.3017-3025.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  DNAse footprinting: a simple method for the detection of protein-DNA binding specificity.

Authors:  D J Galas; A Schmitz
Journal:  Nucleic Acids Res       Date:  1978-09       Impact factor: 16.971

2.  DNA-dependent RNA polymerase levels during the response of human peripheral lymphocytes to phytohemagglutinin.

Authors:  J A Jaehning; C C Stewart; R G Roeder
Journal:  Cell       Date:  1975-01       Impact factor: 41.582

3.  The 5'-flanking sequences of Drosophila melanogaster tRNA5Asn genes differentially arrest RNA polymerase III.

Authors:  A Lofquist; S Sharp
Journal:  J Biol Chem       Date:  1986-11-05       Impact factor: 5.157

4.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

5.  Functions of and interactions between the A and B blocks in adenovirus type 2-specific VARNA1 gene.

Authors:  R E Cannon; G J Wu; J F Railey
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

6.  Analysis of RNA polymerase III transcription complexes by gel filtration.

Authors:  M F Carey; S P Gerrard; N R Cozzarelli
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

7.  Functional analysis of fractionated Drosophila Kc cell tRNA gene transcription components.

Authors:  D J Burke; D Söll
Journal:  J Biol Chem       Date:  1985-01-25       Impact factor: 5.157

8.  Correlations between transcription of a yeast tRNA gene and transcription factor-DNA interactions.

Authors:  D J Stillman; A L Sivertsen; P G Zentner; E P Geiduschek
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

9.  Separation of TFIIIC into two functional components by sequence specific DNA affinity chromatography.

Authors:  N Dean; A J Berk
Journal:  Nucleic Acids Res       Date:  1987-12-10       Impact factor: 16.971

10.  Structural features of yeast tRNA genes which affect transcription factor binding.

Authors:  R E Baker; B D Hall
Journal:  EMBO J       Date:  1984-12-01       Impact factor: 11.598

View more
  29 in total

Review 1.  Survey and summary: transcription by RNA polymerases I and III.

Authors:  M R Paule; R J White
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

2.  Evidence for a posttranscriptional role of a TFIIICalpha-like protein in Chironomus tentans.

Authors:  Nafiseh Sabri; Ann-Kristin Ostlund Farrants; Ulf Hellman; Neus Visa
Journal:  Mol Biol Cell       Date:  2002-05       Impact factor: 4.138

Review 3.  RNA polymerase III transcription: its control by tumor suppressors and its deregulation by transforming agents.

Authors:  T R Brown; P H Scott; T Stein; A G Winter; R J White
Journal:  Gene Expr       Date:  2000

4.  Retinoblastoma protein disrupts interactions required for RNA polymerase III transcription.

Authors:  J E Sutcliffe; T R Brown; S J Allison; P H Scott; R J White
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

5.  The mitogen-activated protein (MAP) kinase ERK induces tRNA synthesis by phosphorylating TFIIIB.

Authors:  Zoe A Felton-Edkins; Jennifer A Fairley; Emma L Graham; Imogen M Johnston; Robert J White; Pamela H Scott
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

6.  A carboxy-terminal basic region controls RNA polymerase III transcription factor activity of human La protein.

Authors:  J L Goodier; H Fan; R J Maraia
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

Review 7.  Relationship of eukaryotic DNA replication to committed gene expression: general theory for gene control.

Authors:  L P Villarreal
Journal:  Microbiol Rev       Date:  1991-09

8.  Transcription termination factor La is also an initiation factor for RNA polymerase III.

Authors:  R J Maraia
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

9.  TFIIIC1 acts through a downstream region to stabilize TFIIIC2 binding to RNA polymerase III promoters.

Authors:  Z Wang; R G Roeder
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

10.  Identification of an autonomously initiating RNA polymerase III holoenzyme containing a novel factor that is selectively inactivated during protein synthesis inhibition.

Authors:  Z Wang; T Luo; R G Roeder
Journal:  Genes Dev       Date:  1997-09-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.